Titan Pharmaceuticals
TTNP
#10544
Rank
NZ$10.44 M
Marketcap
NZ$7.85
Share price
-3.76%
Change (1 day)
17.68%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.47. In 2023 the company made an earnings per share (EPS) of NZ-$12.62 an increase over its 2022 EPS that were of NZ-$25.86.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.62-51.22%
2022NZ-$25.86-15.61%
2021NZ-$30.65-81.37%
2020NZ-$164.48-77.52%
2019NZ-$731.82-56.32%
2018NZ-$1,675-59.51%
2017NZ-$4,138-371.81%
2016NZ$1,523-144.35%
2015NZ-$3,433300%
2014NZ-$858.17-121.54%
2013NZ$3,984-151.38%
2012NZ-$7,754-11.54%
2011NZ-$8,766188.89%
2010NZ-$3,034-10%
2009NZ-$3,371
2007NZ-$13,823-2.38%
2006NZ-$14,160-39.13%
2005NZ-$23,262-16.87%
2004NZ-$27,982-22.43%
2003NZ-$36,0744.9%
2002NZ-$34,38861.9%
2001NZ-$21,240-13.7%
2000NZ-$24,61165.01%
1999NZ-$14,915-35.87%
1998NZ-$23,259-1824.71%
1997NZ$1,349-102.4%
1996NZ-$56,302

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.97-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.26-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.42-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.48-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.43-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.62-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA